FOXP3 expression in duodenal mucosa: Unique role in pathogenesis and differential diagnosis of celiac disease

被引:0
作者
Yilmaz, F. [1 ]
Atay, K. [2 ]
机构
[1] Mardin Training & Res Hosp, Pathol Lab, Mardin, Turkiye
[2] Mardin Training & Res Hosp, Adult Gastroenterol Clin, Mardin, Turkiye
关键词
Celiac disease; FOXP3; Gluten-sensitive enteropathy; Intraepithelial lymphocytes; Regulatory T lymphocytes; REGULATORY T-CELLS; SMALL-BOWEL MUCOSA; SMALL-INTESTINAL MUCOSA; DENDRITIC CELLS; ADAPTIVE IMMUNITY; CHILDREN; IL-15; DENSITY; TIME;
D O I
10.1016/j.anndiagpath.2024.152393
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Forkhead box protein P3 (FOXP3) positive regulatory T lymphocytes are indispensable in the inflammatory homeostasis of the gastrointestinal tract and represent a significant subset of regulatory cells in inflammatory, autoimmune, and neoplastic conditions. This study aimed to elucidate the potential of FOXP3 expression in diagnosing and pathogenesis of celiac disease (CD) by comparing duodenal biopsies of CD cases with non-CD ones, some of which had increased intraepithelial lymphocytes (IELs). Two hundred sixty-one duodenal tissues of patients who applied to adult gastroenterology were reevaluated for immunohistochemical analysis. After excluding patients on a gluten-free diet (n = 44), the CD (n = 97) and non-CD (n = 120) groups were divided based on clinical complaints that could be associated with CD (intestinal or extraintestinal), serologic and histologic findings. The specific threshold was determined by receiver operating characteristic (ROC) analysis, and its relationship with CD diagnosis and clinicopathological data was evaluated. ROC analysis offered a ">14" cutoff value for diagnosing CD, for which AUC (Area Under The Curve): 0.968, p < 0.0001, sensitivity: 92.8, specificity: 91.7, positive and negative predictive values were 90 % and 94 %, respectively. High FOXP3 expression was associated with higher IEL, diagnosis of CD, more severe histologic (higher Marsh score) and endoscopic (scalloping) findings, and higher anti-tissue transglutaminase and anti-endomysium IgA titers (p < 0.001). It also correlates with IEL in CD patients and is unaffected by the increase in IEL and the presence of gastric Helicobacter Pylori in the non-CD group. FOXP3 is a sensitive and specific marker for diagnosing CD despite inflammatory conditions resulting from non-CD causes.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Duodenal mucosa of untreated celiac disease patients has altered expression of the GAS6 and PROS1 and the negative regulator tyrosine kinase TAM receptors subfamily
    Perez, Federico
    Iribarren, Maria Luz
    Olexen, Cinthia Mariel
    Ruera, Carolina Nayme
    Errasti, Andrea Emilse
    Guzman, Luciana
    Garbi, Laura
    Silva, Eugenio Antonio Carrera
    Chirdo, Fernando Gabriel
    CLINICAL IMMUNOLOGY, 2024, 263
  • [42] Differential effects of decoy receptor- and antibody-mediated tumour necrosis factor blockage on FoxP3 expression in responsive arthritis patients
    Ryder, L. Rebekka
    Ryder, Lars P.
    Bartels, Else M.
    Woetmann, Anders
    Madsen, Hans O.
    Odum, Niels
    Danneskiold-Samsoe, Bente
    Ribel-Madsen, Soren
    Bliddal, Henning
    APMIS, 2013, 121 (04) : 337 - 347
  • [43] FOXP3 Expression Is Upregulated in CD4+T Cells in Progressive HIV-1 Infection and Is a Marker of Disease Severity
    Suchard, Melinda S.
    Mayne, Elizabeth
    Green, Victoria A.
    Shalekoff, Sharon
    Donninger, Samantha L.
    Stevens, Wendy S.
    Gray, Clive M.
    Tiemessen, Caroline T.
    PLOS ONE, 2010, 5 (07):
  • [44] The kinetics of mTORC1 activation associates with FOXP3 expression pattern of CD4+T cells and outcome of steroid-sensitive minimal change disease
    Chen, Guochun
    Zeng, Mengru
    Liu, Zhiwen
    Zhou, Mi
    Zha, Jie
    Zhang, Lei
    Chen, Huihui
    Liu, Hong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 122
  • [45] The influence of statin monotherapy and statin-ezetimibe combined therapy on FoxP3 and IL 10 mRNA expression in patients with coronary artery disease
    Jackowska, Paulina
    Chalubinski, Maciej
    Luczak, Emilia
    Wojdan, Katarzyna
    Gorzelak-Pabis, Paulina
    Olszewska-Banaszczyk, Malgorzata
    Broncel, Marlena
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 28 (09): : 1243 - 1248
  • [46] ALLERGY-RELATED CHANGES IN LEVELS OF CD8+CD25+FOXP3brightTREG CELLS AND FOXP3 mRNA EXPRESSION IN PERIPHERAL BLOOD: THE ROLE OF IL-10 OR TGF-β
    Eusebio, M.
    Kuna, P.
    Kraszula, L.
    Kupczyk, M.
    Pietruczuk, M.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2014, 28 (03) : 461 - 470
  • [47] Genome-wide gene expression analysis for target genes to differentiate patients with intestinal tuberculosis and Crohn's disease and discriminative value of FOXP3 mRNA expression
    Ahuja, Vineet
    Subodh, Swati
    Tuteja, Amit
    Mishra, Veena
    Garg, Sushil Kumar
    Gupta, Neha
    Makharia, Govind
    Acharya, S. K.
    GASTROENTEROLOGY REPORT, 2016, 4 (01): : 59 - 67
  • [48] Peripheral blood CD4+T cell populations by CD25 and Foxp3 expression as a potential biomarker: reflecting inflammatory activity in chronic obstructive pulmonary disease
    Meng, Zhao-Ji
    Wu, Jiang-Hua
    Zhou, Mei
    Sun, Sheng-Wen
    Miao, Shuai-Ying
    Han, Hong-Li
    Chen, Long
    Xiong, Xian-Zhi
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 1669 - 1680
  • [49] Correlation of Serum Vitamin A Levels with Disease Activity Indices and Colonic IL-23R and FOXP3 mRNA Expression in Ulcerative Colitis Patients
    Verma, P.
    Subodh, S.
    Tiwari, V.
    Rampal, R.
    Tuteja, A.
    Toteja, G. S.
    Gupta, S. D.
    Ahuja, V.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2016, 84 (02) : 110 - 117
  • [50] Circulating Levels of IL-35 and Gene Expression of FoxP3 in Coronary Artery Disease: Is There Any Interplay Between Them and 25-Hydroxyvitamin D3?
    Shateri, Hossein
    Fadaei, Reza
    Najafi, Mahdi
    Vatannejad, Akram
    Teimouri, Maryam
    Zali, Fatemeh
    Emamgholipour, Solaleh
    Parvaz, Eskandar
    Asadnia, Mostafa
    Doosti, Mahmood
    CLINICAL LABORATORY, 2018, 64 (04) : 483 - 490